ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11451-500mg |
|
52152-93-9 |
Cefsulodin (sodium salt)
|
0 | C22H19N4O8S2 • Na | |
GC11451-250mg |
|
52152-93-9 |
Cefsulodin (sodium salt)
|
0 | C22H19N4O8S2 • Na | |
GC11450-50mg |
|
6429-04-5 |
Tetrahydropapaverine HCl
|
0 | C20H25NO4.HCl | |
GC11450-10mg |
|
6429-04-5 |
Tetrahydropapaverine HCl
|
0 | C20H25NO4.HCl | |
GC11449-50mg |
|
84454-35-3 |
β-CCB
|
0 | C16H16N2O2 | |
GC11449-10mg |
|
84454-35-3 |
β-CCB
|
0 | C16H16N2O2 | |
GC11448-100mg |
|
203737-93-3 |
Istaroxime
|
0 | C21H32N2O3 | |
GC11448-50mg |
|
203737-93-3 |
Istaroxime
|
0 | C21H32N2O3 | |
GC11448-2mg |
|
203737-93-3 |
Istaroxime
|
0 | C21H32N2O3 | |
GC11448-10mg |
|
203737-93-3 |
Istaroxime
|
0 | C21H32N2O3 | |
GC11448-5mg |
|
203737-93-3 |
Istaroxime
|
0 | C21H32N2O3 | |
GC11447-10mM (in 1mL DMSO) |
|
85650-52-8 |
Mirtazapine
|
0 | C17H19N3 | |
GC11447-50mg |
|
85650-52-8 |
Mirtazapine
|
0 | C17H19N3 | |
GC11447-10mg |
|
85650-52-8 |
Mirtazapine
|
0 | C17H19N3 | |
GC11446-50mg |
|
5369-00-6 |
QX 222
|
0 | C13H21ClN2O | |
GC11446-10mg |
|
5369-00-6 |
QX 222
|
0 | C13H21ClN2O | |
GC11445-50mg |
|
1364488-67-4 |
YH239-EE
|
0 | C25H27Cl2N3O4 | |
GC11445-10mg |
|
1364488-67-4 |
YH239-EE
|
0 | C25H27Cl2N3O4 | |
GC11443-10mM (in 1mL DMSO) |
|
109-57-9 |
Allylthiourea
|
0 | C4H8N2S | |
GC11443-50mg |
|
109-57-9 |
Allylthiourea
|
0 | C4H8N2S | |